Yan Leyfman։ What Determines Whether an Allogeneic CAR-T Product Succeeds or Gets Rejected? / cancer, CAR-T therapy, ...

A patient can move into a higher-risk category through rising blasts, worsening cytopenias, adverse genetics, or a ...

A Personal Reminder for Breast Cancer Awareness Month / Amanda Impellizzeri, Breast Cancer, breast cancer awareness month, ...

Celebrating a Mentor Who Shaped a Journey in Oncology / Amit Oza, cancer, IGCS Conference, Ilaria Colombo, OncoDaily, ...

EU Presidency Conference Connects Innovation With Better Health Outcomes / Alexander Roediger, Blaine Gaffney, cancer, Denis ...

PACIFIC-R durvalumab data show 49.2% 5-year overall survival and 35.2% 5-year real-world PFS after chemoradiotherapy for ...

Myeloma Paper of the Day, October 5th, Suggested by Robert Orlowski / Blood Cancer Journal, cancer, Caroline A. Heckman, ...

Opportunity to Celebrate the Quiet Champions of Ovarian Cancer in Your Community - World Ovarian Cancer Coalition / cancer, ...

Excited to Have Been Selected for the 2027 EORTC Early Career Investigator Programme! / cancer, EORTC, Manuel Mazariegos Rubi ...

Welcoming Michael R. Caputo as a New Member of the President’s Cancer Panel / cancer, Michael R. Caputo, OncoDaily, Oncology, ...

Can Innovation Transform GI and Stomach Cancer Care? / Amanda Pullinger, cancer, Kai-Keen Shiu, Lauren McKenzie, Marnix ...

IARC Perspective on Lung Cancer Screening in NEJM / Abhishek Shankar, Ali Saeed Al‑Zahrani, Arn Migowski, Asia, Béatrice ...